Senti Biosciences Inc. (SNTI)
NASDAQ: SNTI
· Real-Time Price · USD
1.55
0.02 (1.31%)
At close: Aug 15, 2025, 3:59 PM
1.50
-3.19%
After-hours: Aug 15, 2025, 07:51 PM EDT
Senti Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.86M | 5.86M | 5.86M | 333K | 588K | 1.52M | 2.56M | 2.29M | 3.8M | 3.97M | 3.79M | 4.27M | 3.43M | 3.1M | 2.32M | 1.78M | 852K | 74K |
Cost of Revenue | 4.4M | 4.39M | 5.86M | 4.4M | 30.09M | 29.84M | 39.69M | 39.16M | 13.47M | 13.99M | 10.28M | 15.74M | 16M | 19.5M | 16.8M | 13.95M | 13.69M | 8.46M |
Gross Profit | 1.45M | 1.46M | n/a | -4.07M | -29.5M | -28.31M | -37.13M | -36.88M | -9.68M | -10.03M | -6.49M | -11.47M | -12.57M | -16.4M | -14.48M | -12.17M | -12.84M | -8.38M |
Operating Income | -64.58M | -61.13M | -61.04M | -63.3M | -91.96M | -98.24M | -101.77M | -103.36M | -76.57M | -78.71M | -70.63M | -61.5M | -55.84M | -43.06M | -31.31M | -26.97M | -15.55M | -6.55M |
Interest Income | 97K | 63K | n/a | 1.14M | 1.58M | 2.13M | 2.86M | 3.57M | 3.52M | 2.76M | 1.7M | 577K | 40K | 15K | 11K | 8K | 3K | 1K |
Pretax Income | -58.32M | -54.79M | -52.79M | -70.87M | -78.62M | -86.11M | -92.72M | -92.24M | -72.27M | -65.12M | -58.21M | -50.9M | -45.67M | -46.13M | -34.32M | -24.49M | -13.08M | -1.08M |
Net Income | -58.32M | -54.79M | -52.79M | -70.9M | -56.95M | -64.45M | -71.06M | -70.55M | -72.27M | -65.12M | -58.21M | -50.9M | -45.67M | -46.13M | -34.32M | -24.49M | -13.08M | -1.08M |
Selling & General & Admin | 29.19M | 27.16M | 26.37M | 23.89M | 27.07M | 33.2M | 36.68M | 39.77M | 41.13M | 45.39M | 40.85M | 35.2M | 31.53M | 22.2M | 16.94M | 14.67M | 7.55M | 3M |
Research & Development | 35.77M | 35.12M | 34.36M | 35.45M | 35.88M | 37.69M | 40.48M | 40.52M | 39.49M | 37.78M | 34.07M | 31.32M | 28.67M | 24.66M | 21.96M | 19.1M | 13.69M | 8.46M |
Other Expenses | 313K | 313K | 313K | 313K | 885K | 1.82M | 1.57M | 3.38M | 2.49M | 1.31M | 1.31M | -510K | -489K | -3.25M | -3M | -2.99M | -3.01M | n/a |
Operating Expenses | 65.28M | 63.31M | 61.76M | 60.36M | 63.59M | 70.81M | 76.83M | 79.96M | 80.37M | 82.67M | 74.42M | 65.77M | 59.27M | 46.16M | 33.55M | 24.6M | 12.25M | 2.48M |
Interest Expense | n/a | n/a | n/a | 1.11M | 1.11M | 1.11M | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.41M | 1.2M | n/a | -1.58M | -1.58M | -367K | 834K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.31M | -4.31M | -4.31M | -4.31M |
Cost & Expenses | 69.68M | 66.24M | 66.14M | 63.3M | 66.52M | 73.74M | 78.31M | 79.96M | 80.37M | 82.67M | 74.42M | 65.77M | 59.27M | 46.16M | 33.55M | 28.16M | 15.81M | 6.03M |
Income Tax Expense | n/a | n/a | n/a | 28K | 28K | -1.18M | -2.29M | -2.32M | -3.35M | -2.14M | -1.05M | -1.05M | -10.16K | -10.16K | 13K | 4K | n/a | n/a |
Shares Outstanding (Basic) | 26.08M | 4.6M | 4.6M | 4.58M | 4.57M | 4.57M | 4.5M | 4.45M | 4.43M | 4.41M | 4.38M | 4.34M | 4.35M | 4.37M | 4.37M | 4.37M | 4.37M | 2.95M |
Shares Outstanding (Diluted) | 26.08M | 4.6M | 4.6M | 4.58M | 4.57M | 4.57M | 4.5M | 4.45M | 4.43M | 4.41M | 4.38M | 4.34M | 4.35M | 4.37M | 4.37M | 4.37M | 4.37M | 2.95M |
EPS (Basic) | -10.07 | -11.96 | -11.54 | -15.57 | -12.62 | -14.39 | -15.99 | -15.99 | -16.46 | -14.89 | -13.34 | -11.68 | -10.46 | -10.56 | -7.86 | -6.11 | -3.5 | -0.75 |
EPS (Diluted) | -10.07 | -11.96 | -11.54 | -15.57 | -12.62 | -14.39 | -15.99 | -15.99 | -16.46 | -14.89 | -13.34 | -11.68 | -10.46 | -10.56 | -7.86 | -6.11 | -3.5 | -0.75 |
EBITDA | -46.63M | -45.26M | -45.17M | -57.38M | -59.88M | -65.48M | -68.43M | -70.78M | -70.45M | -74.74M | -68.46M | -59.56M | -55.17M | -42.22M | -30.7M | -26.46M | -15.23M | -6.42M |
EBIT | 812K | 2.19M | n/a | -62.99M | -66.27M | -71.61M | -74.03M | -75.62M | -72.18M | -75.26M | -68.29M | -59.16M | -55.84M | -43.06M | -31.31M | -26.97M | -15.55M | -6.55M |
Depreciation & Amortization | 16K | 7K | n/a | 5.87M | 6.22M | 5.96M | 5.43M | 4.9M | 4.12M | 4.64M | 4.72M | 4.81M | 4.65M | 3.1M | 2.25M | 1.35M | 479K | 297K |